Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: Validation in phantoms and in patients with chronic liver disease

Journal of Magnetic Resonance Imaging

Volumn 33, Issue 6, 2011, Pages 1390-1398

  Lee, Seung Soo ^a   Lee, Youngjoo ^a,b   Kim, Namkug ^a   Kim, Seong Who ^a   Byun, Jae Ho ^a   Park, Seong Ho ^a   Lee, Moon Gyu ^a   Ha, Hyun Kwon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b SAMSUNG Electronics   (South Korea)

Author keywords

hepatic steatosis; MR imaging; MR spectroscopy: chronic liver disease

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; FATTY LIVER; FEMALE; FRACTIONATION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VALIDATION STUDY;

ADIPOSE TISSUE; ADULT; AGED; END STAGE LIVER DISEASE; FATTY LIVER; FEMALE; HUMANS; IRON; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS;

EID: 79958248631     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22583     Document Type: Article

References (33)

1. Adams LA, Sanderson S, Lindor KD, Angulo P,. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-138. (Pubitemid 40038911)
2. Harrison SA, Torgerson S, Hayashi PH,. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003; 98: 2042-2047. (Pubitemid 37185803)
3. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ,. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669. (Pubitemid 29109578)
4. Cheung O, Sanyal AJ,. Hepatitis C infection and nonalcoholic fatty liver disease. Clin Liver Dis 2008; 12: 573-585, viii-ix. (Pubitemid 351952473)
5. Powell EE, Jonsson JR, Clouston AD,. Steatosis: co-factor in other liver diseases. Hepatology 2005; 42: 5-13. (Pubitemid 40911303)
6. Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK,. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol 2005; 43: 38-44. (Pubitemid 40805271)
7. Powell EE, Ali A, Clouston AD, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 2005; 129: 1937-1943. (Pubitemid 41772971)
8. O'Regan DP, Callaghan MF, Wylezinska-Arridge M, et al. Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T-feasibility. Radiology 2008; 247: 550-557.
9. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006; 239: 105-112.
10. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750. (Pubitemid 34977081)
11. Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276: E977-989. (Pubitemid 29249618)
12. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-468. (Pubitemid 40110657)
13. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009; 251: 67-76.
14. Borra RJ, Salo S, Dean K, et al. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology 2009; 250: 130-136.
15. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA,. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997; 15: 287-293. (Pubitemid 27280484)
16. Guiu B, Petit JM, Loffroy R, et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009; 250: 95-102.
17. Kim SH, Lee JM, Han JK, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging-correlation with histopathologic findings. Radiology 2006; 240: 116-129. (Pubitemid 43902601)
18. Pineda N, Sharma P, Xu Q, Hu X, Vos M, Martin DR,. Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy-a rapid and accurate technique. Radiology 2009; 252: 568-576.
19. Bydder M, Yokoo T, Hamilton G, et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 2008; 26: 347-359.
20. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB,. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007; 58: 354-364. (Pubitemid 47267653)
21. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 2005; 237: 1048-1055. (Pubitemid 41636400)
22. Reeder SB, Robson PM, Yu H, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 2009; 29: 1332-1339.
23. Hines CD, Yu H, Shimakawa A, McKenzie CA, Brittain JH, Reeder SB,. T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom. J Magn Reson Imaging 2009; 30: 1215-1222.
24. Westphalen AC, Qayyum A, Yeh BM, et al. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 2007; 242: 450-455. (Pubitemid 46146198)
25. Bernard CP, Liney GP, Manton DJ, Turnbull LW, Langton CM,. Comparison of fat quantification methods: a phantom study at 3.0T. J Magn Reson Imaging 2008; 27: 192-197.
26. Chandarana H, Lim RP, Jensen JH, et al. Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence. AJR Am J Roentgenol 2009; 193: 1261-1267.
27. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106: 1460-1465. (Pubitemid 41129616)
28. Reeder SB, Wen Z, Yu H, et al. Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med 2004; 51: 35-45. (Pubitemid 38095700)
29. Johnson NA, Walton DW, Sachinwalla T, et al. Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology 2008; 47: 1513-1523. (Pubitemid 351702735)
30. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906. (Pubitemid 40824701)
31. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321. (Pubitemid 40770284)
32. d'Assignies G, Ruel M, Khiat A, et al. Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol 2009; 19: 2033-2040.
33. Lee SS, Park SH, Kim HJ, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol; 52: 579-585.